Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As compared with fulvestrant alone, the combination more than doubled the median ...
Cell division is an essential process for all life on Earth, yet the exact mechanisms by which cells divide during early ...
Cell division is an essential process for all life on earth, yet the exact mechanisms by which cells divide during early ...
Life begins with a single fertilized cell that gradually transforms into a multicellular organism. This process requires ...
The field of sepsis research has advanced significantly in recent years, particularly regarding the interplay between immune responses and multiple forms of ...